Entero Therapeutics's total assets for Q1 2025 were $85.20M, a decrease of -0.24% from the previous quarter. ENTO total liabilities were $28.74M for the fiscal quarter, a 4.11% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.